top of page

Peptide Therapy 

Individualized, provider-directed peptide protocols built around a thorough medical evaluation.

What are Peptides?
Peptides are short chains of amino acids that act as precise signaling molecules in the body — telling cells to repair, regenerate, or produce hormones more efficiently. At Belle Medical, peptide therapy is offered as part of an individualized wellness plan, prescribed and monitored by Brianna Clendenin, APRN, based on your labs, health history, and goals. Peptides are currently not FDA approved and results may vary.
 

Growth Hormone Support

Sermorelin and Tesamorelin are growth-hormone-releasing peptides that stimulate your pituitary gland to produce its own growth hormone — supporting lean body composition, recovery, sleep quality, and energy as part of a broader wellness or anti-aging protocol.
 

Recovery & Repair

For patients recovering from injury or managing chronic joint and tendon discomfort, Belle Medical can discuss recovery-focused peptide options during a consultation. Availability depends on current FDA compounding status and your individualized evaluation.
 

Sexual Health

PT-141 (bremelanotide) is an FDA-approved option for low sexual desire, working centrally on arousal pathways rather than blood flow alone — appropriate for both men and women following an evaluation.
 

Skin & Anti-Aging

GHK-Cu (copper peptide) is available through our provider-directed, home-delivery prescription skincare line to support firmness, hydration, and skin repair as part of a broader dermatology or aesthetics plan.
 

What to expect

  • A consultation with Brianna to review your health history, labs, and goals.

  • A personalized protocol — peptide selection, dose, and duration tailored to you.

  • Ongoing monitoring and adjustment as part of your care plan.

  • Most peptide protocols are self-administered at home after in-office training, similar to our NAD+ program.

     

Safety & disclaimers

  • Prescription required. Evaluation and informed consent are completed before treatment begins.

  • Peptide sourcing and availability are subject to current FDA compounding regulations, which are evolving in 2026.

  • All treatments are individualized and medically supervised. Results may vary and are not guaranteed.

  • Some compounded peptides are not FDA-approved as drugs; where an FDA-approved option exists (e.g., PT-141/Vyleesi), that will be discussed.

bottom of page